AimedBio IPO Raises Hopes Of Investor Appetite For Korean Biotech

Out-Licensing Deals Fuel Optimism

 
• By Jung Won Shin
  
IPO
Strong Performance Of Recent Kosdaq Debutants Helps AimedBio's IPO (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business